Cargando…

Drugs acting on the pregnant uterus

In this review we overview the mechanisms responsible for uterine contractility and relaxation. We then use this as the basis for discussing the two major uterotonins, oxytocin and prostaglandins followed by currently available (although often unlicensed) tocolytics; progesterone, magnesium, calcium...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrowsmith, Sarah, Kendrick, Annabelle, Wray, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicine Pub 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892726/
https://www.ncbi.nlm.nih.gov/pubmed/24443652
http://dx.doi.org/10.1016/j.ogrm.2010.05.001
_version_ 1782299572791410688
author Arrowsmith, Sarah
Kendrick, Annabelle
Wray, Susan
author_facet Arrowsmith, Sarah
Kendrick, Annabelle
Wray, Susan
author_sort Arrowsmith, Sarah
collection PubMed
description In this review we overview the mechanisms responsible for uterine contractility and relaxation. We then use this as the basis for discussing the two major uterotonins, oxytocin and prostaglandins followed by currently available (although often unlicensed) tocolytics; progesterone, magnesium, calcium channel blockers, oxytocin receptor blockers, β-adrenergic receptor agonists, prostaglandin synthesis inhibitors and nitric oxide donors. In this brief review we have concentrated on the most important mechanisms of action and data obtained on human tissue. By focussing on mechanisms, meta-analyses and Cochrane literature reviews, our aim is to provide insight for clinical usefulness, and highlight where further research is required and where the targets may be.
format Online
Article
Text
id pubmed-3892726
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medicine Pub
record_format MEDLINE/PubMed
spelling pubmed-38927262014-01-15 Drugs acting on the pregnant uterus Arrowsmith, Sarah Kendrick, Annabelle Wray, Susan Obstet Gynaecol Reprod Med Review In this review we overview the mechanisms responsible for uterine contractility and relaxation. We then use this as the basis for discussing the two major uterotonins, oxytocin and prostaglandins followed by currently available (although often unlicensed) tocolytics; progesterone, magnesium, calcium channel blockers, oxytocin receptor blockers, β-adrenergic receptor agonists, prostaglandin synthesis inhibitors and nitric oxide donors. In this brief review we have concentrated on the most important mechanisms of action and data obtained on human tissue. By focussing on mechanisms, meta-analyses and Cochrane literature reviews, our aim is to provide insight for clinical usefulness, and highlight where further research is required and where the targets may be. Medicine Pub 2010-08 /pmc/articles/PMC3892726/ /pubmed/24443652 http://dx.doi.org/10.1016/j.ogrm.2010.05.001 Text en © 2010 Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/ Open Access under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) license
spellingShingle Review
Arrowsmith, Sarah
Kendrick, Annabelle
Wray, Susan
Drugs acting on the pregnant uterus
title Drugs acting on the pregnant uterus
title_full Drugs acting on the pregnant uterus
title_fullStr Drugs acting on the pregnant uterus
title_full_unstemmed Drugs acting on the pregnant uterus
title_short Drugs acting on the pregnant uterus
title_sort drugs acting on the pregnant uterus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892726/
https://www.ncbi.nlm.nih.gov/pubmed/24443652
http://dx.doi.org/10.1016/j.ogrm.2010.05.001
work_keys_str_mv AT arrowsmithsarah drugsactingonthepregnantuterus
AT kendrickannabelle drugsactingonthepregnantuterus
AT wraysusan drugsactingonthepregnantuterus